Randomized, open, parallel controlled clinical study of Haiai Decoction combined with oral administration of finasteride for male androgenic alopecia
- Conditions
- androgenic alopecia
- Registration Number
- ITMCTR2000003332
- Lead Sponsor
- Shanghai Tongji Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- Not specified
1. The typical clinical manifestations were in accordance with the diagnosis of AGA, and the degree of hair loss was in accordance with the BASP classification of androgenic hair loss;
2. In general, patients with good condition (no previous heart, systemic or scalp diseases) have not used any drugs that may affect hair growth (antihypertensive drugs, hormones, cytotoxic drugs, anti androgen drugs, etc.) within the first 3 months of the study;
3. Patients who agree to participate in observation and follow-up, are willing to receive follow-up, and can cooperate closely in the whole process.
1. Finasteride was taken orally 18 months before the start of the experiment;
2. Use local or systemic drugs that affect hair growth within 12 months;
3. History of hair transplantation;
4. Systemic or scalp diseases that may affect hair growth.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method